1. Cross-protective efficacy of a conserved Leishmania braziliensis recombinant protein as a candidate vaccine against visceral leishmaniasis. (August 2018) Authors: Santos, T. Teodoro de Oliveira; Duarte, M.C.; Martins, V.T.; Lage, D.P.; Costa, L.E.; Fumagalli, M.A.C.; Salles, B.C.S.; Dias, D.S.; Ribeiro, P.A.F.; Ramos, F.F.; Lima, M.P.; Tavares, G.D.S.V.; Souza, D.M.; Roatt, B.M.; Coelho, E.A.F. Journal: International journal of infectious diseases Issue: Volume 73(2018)Supplement Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PORTUGUESE REAL‐LIFE EXPERIENCE WITH IBRUTINIB OUTSIDE CLINICAL TRIALS – A MULTICENTER ANALYSIS. (June 2017) Authors: Silva, S.; Espada, E.; Melo, J.A.; Lima, M.P.; Ionita, A.; Carda, J.P.; Andrade, J.; Neves, M.; Cabral, R.; Mendes, T.; Gaspar, C.; Alves, D.; Pina, F.; Botelho de Sousa, A.; Coelho, H.; Montalvão, A.; Vitória, H.; Lima, F.; Coutinho, J.; Lúcio, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗